PARP Quiz! Strategies for Targeting DNA Repair in Prostate Cancer

Watch this on-demand Webcast capturing a live CCO Webinar featuring expert presentations on PARP inhibition in patients with prostate cancer, including the clinical role of DNA damage repair genes and genetic testing, as well as optimal use of PARP inhibitors in the clinic.

Celestia S. Higano, MD, FACP
Program Director Charles J. Ryan, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Released: August 10, 2020 Expired: August 9, 2021

Clinical Role of PARP1, BRCA, and Other DNA Damage Repair Genes in Prostate Cancer (15 mins)

Genetic Testing in Prostate Cancer (18 mins)

Targeting DNA Repair Defects in Prostate Cancer: The Role of PARP Inhibitors (33 mins)

Panel Discussion (14 mins)

Download this short summary slideset of key takeaways from a live CCO Webinar focused on the use of PARP inhibitors in prostate cancer, including guidance on genetic testing for DNA repair defects.

Celestia S. Higano, MD, FACP Charles J. Ryan, MD Released: July 14, 2020

Get up to date on how PARP inhibitors target tumor cells with DNA repair deficiencies as well as germline and somatic testing in patients with prostate cancer.

Celestia S. Higano, MD, FACP Released: July 9, 2020

Get up to date on the use of newly approved and emerging PARP inhibitors for the treatment of patients with metastatic CRPC and DNA repair defects. Includes a case study!

Celestia S. Higano, MD, FACP Charles J. Ryan, MD Released: July 9, 2020